Concepedia

Author

Monica Milano

University of MilanORCID

Also Known As

M MILANO, M Milano, M. Milano, M. T. Milano, Martina Milano, Miguel Milano, Monica Milano

56

Publications

699

Citations

11

H-Index

6

Concepts

All Affiliations

University of MilanFondazione IRCCS Istituto Nazionale dei TumoriEuropean Institute of OncologyIstituti di Ricovero e Cura a Carattere ScientificoUniversity of Naples Federico II
MM

About

Monica Milano is an author at University of Milan specializing in oncology, cancer therapeutics, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

32

2

Pharmacology

2

2

32

3

Cancer Therapeutics

2

2

32

4

Breast Cancer

2

2

32

5

Oncology

2

2

32

Monica Milano

×

8

Publications

229

Citations

8

H-Index

YearCitations

Chemotherapy versus endocrine therapy as first-line treatment in patients with luminal-like HER2-negative metastatic breast cancer: A propensity score analysis

Marta Bonotto, Lorenzo Gerratana, Massimo Di Maïo,

The Breast

2016

55

The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer

Claudio Vernieri, Alessia Mennitto, Michele Prisciandaro,

Scientific Reports

2018

53

Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis

Piera Gargiulo, Matilde Pensabene, Monica Milano,

BMC Cancer

2016

39

Validation of the ONKOTEV Risk Prediction Model for Venous Thromboembolism in Outpatients With Cancer

Chiara Alessandra Cella, M. Knoedler, Marcia Hall,

JAMA Network Open

2023

20

Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer: A Retrospective Comparison of Efficacy and Safety Profiles

Claudio Vernieri, Michele Prisciandaro, Monica Milano,

Clinical Breast Cancer

2018

19

Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists

Margaret Ottaviano, Marcello Curvietto, Pasquale Rescigno,

Journal for ImmunoTherapy of Cancer

2020

19

Antitumor activity and safety profile of weekly carboplatin plus paclitaxel in metastatic breast cancer: a ten-year, monocentric, retrospective study

Claudio Vernieri, Monica Milano, Alessia Mennitto,

Breast Cancer Research and Treatment

2017

13

Pegylated Liposomal Doxorubicin (Caelyx®) as Adjuvant Treatment in Early-Stage Luminal B-like Breast Cancer: A Feasibility Phase II Trial

Silvia Dellapasqua, Pamela Trillo Aliaga, Elisabetta Munzone,

Current Oncology

2021

11

Page 1